deepeye Medical

deepeye - preventing blindness is a Health Care startup founded in 2021 and based in Germany. The company aims to tackle vision-threatening retinal diseases that affect over 100 million people globally, with a focus on diseases like wet AMD that are responsible for ⅔ of blindness cases in the EU and US. The €2.50MSeed Round investment received on 07 November 2023 from Bayern Kapital, Springboard Health Angels, YZR Capital, and Arve Capital underscores the confidence of prominent investors in the startup.

deepeye's AI-based precision health platform replicates a proven clinical method, yielding impressive results. By providing ophthalmologists with AI-based optimal therapy prognosis, the company aspires to prevent an additional 1 million people from blindness by 2030. Their pre-clinical AI is utilized by various stakeholders in the healthcare industry to gain insights into therapy data, while their clinical product is on track to offer therapy decision support with just 1 click at the PoC in 2024.

The potential impact of deepeye's technology in preventing blindness, coupled with their strategic approach to leveraging AI in the field of ophthalmology, positions the company as a noteworthy player in the global healthcare landscape. With a clear vision and strong investor backing, deepeye is well-poised to make significant strides in improving retinal therapy outcomes and making a tangible difference in the fight against preventable blindness.